OBJECTIVES: Early microbiological diagnosis of deep sternal wound infections (DSWI) could improve outcomes by allowing targeted antibiotic treatment. This study aims to analyse the utility of superficial sternal wound swabs and blood cultures.
INTRODUCTION
Deep sternal wound infection (DSWI) is an uncommon but serious complication of cardiac surgery. Despite widespread infection control practices and routine antibiotic prophylaxis, the incidence of DSWI has remained stable over time [1] [2] [3] . One of the difficulties lies in diagnosing this condition in its earliest stages, and differentiating it from a relatively benign superficial surgical site infection [2] . The associated challenge is that of empiric at antibiotic choice to treat an apparently superficial sternal wound when the diagnosis of DSWI is suspected or yet to be established. Previous studies have already described the microbiology and pathogenesis of this condition, which have guided standard pre-operative antibiotic prophylaxis [4, 5] . However, this study focuses on the microbiological aspects in order to guide early and appropriate antibiotic choice for the treatment of this potentially devastating condition. The relevance and utility of early superficial sternal wound cultures and blood cultures to predict the pathogen of the DSWI were analysed, as was the presence of prior colonization with multi-resistant organisms (MROs) . Deep sternal cultures were analysed to obtain the microbiological characteristics of this infection and compare it against the prevailing practice in empiric at antibiotic usage.
METHODS
Patient data was obtained retrospectively from our hospital's infection control database. The database aims to prospectively identify surgical complications of DSWI from January 2005 to June 2011. DSWI included both deep incisional and organ-space infection defined as per the Australian Infection Control Association guidelines, which are identical to those defined by the National Nosocomial Infections Surveillance System from CDC Atlanta, USA [6] . Primary microbiological data were obtained from the same database and it identified the pathogens implicated in the first episodes of DSWI post-cardiac surgery both during the inpatient phase and post-discharge.
All microbial isolates identified in the quality control database were analysed for antibiotic sensitivities as reported on a 'laboratory information system' (LIS), of Pathology Queensland. The Vitek ® 2 system was used for final microbial identification and antibiotic susceptibility testing in most instances. Microbiological data concerning superficial sternal swabs and MRO screening swabs from the nose and the perineum were also obtained for each case from the LIS.
Superficial sternal wound cultures and blood cultures were included if they were obtained within 1 week prior to the intraoperative deep sternal tissue samples. All surgical patients were screened for colonization with MRO pre-operatively, postoperatively and periodically if they had a prolonged stay in the intensive care unit. Although this is predominantly a microbiological study, we also obtained relevant patient characteristics from the aforementioned database in order to note any risk factors for particular groups of organisms [e.g. coagulasenegative Staphylococci (CoNS), Staphylococcus aureus, Enterobacteriaceae].
RESULTS
During the study period of 2005-2011, 70 of the 6876 patients undergoing cardiac surgery at The Prince Charles Hospital in Brisbane developed a DSWI. This incidence of 1% is consistent with other reports from multiple centres internationally [3, 5] . Staphylococcus aureus was the commonest organism cultured from deep sternal tissue (n = 27, 39%) with comparable rates of methicillin-susceptible S.aureus (MSSA) (n = 14, 20%) and methicillin-resistant S.aureus (MRSA) (n = 13, 19%). By comparison, CoNS were cultured from a smaller number of patients (n = 19, 27%), half of which were identified as Staphylococcus epidermidis. Gram-negative organisms were cultured in less than a quarter of the patients (n = 16, 23%) predominantly as pure growth (n = 12, 17%) with a minority as part of polymicrobial growth (n = 4, 6%). Pseudomonas aeruginosa was the commonest gram-negative organism isolated across all samples (n = 4, 6%) although gram-negative bacteria belonging to the 'ESCaPPM' (Enterobacter spp., Serratia spp., Citrobacter freundii, Providencia spp., Proteus vulgaris, Morganella morganii) group were isolated at slightly higher rates (n = 7, 10%; Fig. 1 ). A minority of gramnegative infections could be attributed to lactose-fermenting Enterobacteriaceae sensitive to standard first-line prophylactic antibiotics such as cephazolin (n = 5, 7%). None of the gramnegative organisms identified possessed extended-spectrum beta-lactamases. Patients who had culture-negative deep sternal tissue (n = 7, 10%) may be partly explained by routine use of broad-spectrum antibiotics pre-operatively.
Superficial sternal swabs were done on a majority of patients within a week prior to operative intervention (n = 62, 89%; Fig. 2 ).
To understand the microbiological relevance of a superficial swab, we analysed only the ones that had a corresponding culture-positive deep swab/tissue (n = 57; Fig. 3 ). 'Concordance' was defined as the growth of phenotypically identical organisms from the superficial and deep swab/tissue. Of the 57 'pairs' identified, a larger than expected concordance was found (n = 43, 75%). The discordant pairs were divided between three groups. One group (n = 8) was discordant by virtue of having culturenegative superficial swabs, where six of the deep samples grew CoNS. Another group (n = 6) was discordant as the superficial swabs were reported as 'normal skin flora', but as five of the deep cultures grew various CoNS, these may well have been concordant had the superficial organisms been speciated. And the last discordant group (n = 3) had polymicrobial growth where the superficial cultures identified at least one but not all the organisms grown from deep tissue.
Blood cultures were not done on a number of patients suspected to have DSWI (n = 55, 79%) and even fewer were positive (n = 30). However, a significant proportion of culture-positive blood samples had isolates that were identical to deep sternal cultures (n = 25, 83%). In some instances, positive blood cultures even identified the pathogen of DSWI when the superficial swabs were culture-negative (n = 4).
Thus, the superficial sternal swabs in combination with blood cultures seem to predict the pathogen of the DSWI in 82% of culture-positive DSWI despite >10 and 20% of the patients not having superficial swabs and blood cultures taken, respectively.
The MRO screen, which included nasal and perineal swabs, predicted the pathogen of DSWI in all cases that had a positive MRO screen (n = 13). MRSA was the predominant MRO (n = 12) but vancomycin-resistant Enterococcus was also isolated (n = 1) in a perineal swab. MRSA was isolated pre-operatively on routine screening in only 1% of the cardiac surgical cases during the study period. However, this incidence increases to 19% when there is a DSWI.
Patient characteristics (Table 1) did not predict or predispose to certain groups of pathogens. The rates of smoking, hypertension, diabetes, male sex and impaired left ventricular function were high. This was expected in this patient population as they have been identified as risk factors in other reports [1, 3, 7, 8] .
DISCUSSION
As mentioned above, the rates of DSWI at our institution are in line with international reports. All the cases underwent operative intervention for management of DSWI in addition to receiving empirical broad-spectrum antimicrobial agents to cover methicillin-resistant gram-positive organisms and nosocomial gram-negative organisms. This approach is in keeping with a number of published recommendations [2, [9] [10] [11] [12] . In our centre, a typical antibiotic regimen would include intravenous vancomycin with ticarcillin clavulanate (T/C) as empirical treatment for a purulent sternal wound regardless of whether it is deemed 'superficial' or 'deep' on initial assessment. The duration of empirical treatment tends to be prolonged as antibiotics are rationalized only after results from deep sternal swabs or curettings are made available. This time interval can be several days if one accounts for the time between the appearance of a superficial sternal wound to the diagnosis of DSWI, the time to surgical intervention and finally the time to culture positivity of deep sternal tissue. For empirical treatment, the choice of vancomycin as a firstline agent seems appropriate, as in our study there is almost a 50% chance of encountering a gram-positive pathogen resistant to flucloxacillin. As for the gram-negatives, despite their lower incidence rates (23%), empirical treatment is justified given the seriousness of this infection. Pseudomonas aeruginosa and 'ESCAPPM' organisms were the majority with all isolates initially testing sensitive to T/C. While being aware of inducible resistance to beta-lactams in 'ESCAPPM' organisms, their overall numbers are too small to justify carbapenem use at the outset. Similarly, but at the other end of the spectrum, only a minority of gram-negative organisms would have been sensitive to betalactams without beta-lactamase inhibitors or third-generation cephalosporins. Thus, T/C seems to strike the right balance between prudence and empiricism.
Despite this, the possible problems with the current strategy are manifold. Prolonged empiricism in order to achieve broadspectrum bactericidal activity comes at the cost of early rationalization. And early rationalization is important to achieve the most potent bactericidal activity. This principle is most relevant to the treatment of serious infections due to MSSA. A number of studies have documented worse outcomes with the use of vancomycin for the treatment of serious MSSA infections, particularly bacteraemia and pneumonia [13, 14] . This has been attributed partially to glycopeptides being intrinsically less active against staphylococci than are anti-staphylococcal betalactams [15] .
Our data mirror other studies [3, 5] with regard to the predominance of gram-positive pathogens. Hence, we analysed the predictive value of the various microbiological results for this group of pathogens in order to aid early targeted antibiotic treatment. Specific to S.aureus (both MSSA and MRSA), blood cultures (n = 17) predicted the DSWI pathogen 100% of the time and reinforces its utility as noted in the past [16] . As in other studies, colonization with MRO also appeared to predict the deep pathogen 100% of the time (n = 13) [17, 18] . Although this supports the generally accepted theory of 'endogenous' pathway of infection [19] , a small number of patients (n = 3) with MRSA DSWI had negative MRO screening swabs. However, those three patients were noted to have had MRSA positive blood cultures (n = 2) and superficial swabs (n = 3), which would have supported the use of vancomycin early on in treatment.
The commonest single pathogen in DSWI was MSSA (n = 14) and it was found that all instances of MSSA-positive superficial swabs (n = 11), blood cultures (n = 7) or both (n = 5) predicted its growth as pure colonies from deep sternal tissue. This finding supports early rationalization to a beta-lactam antibiotic when results of superficial swabs or blood cultures become available. The only one instance of discordance in MSSA DSWI was noted when its corresponding superficial swab cultured CoNS, in which case vancomycin would have continued.
With regard to gram-negative DSWI, the predictive value of superficial swabs and blood cultures was inferior when compared with S.aureus. Statistically this finding was not as robust because of smaller overall numbers and their implication in polymicrobial DSWI. However, the absence of gram-negatives from superficial swabs or blood cultures predicted its absence in deep tissue (Table 2 ). This finding may support the cessation of T/C before deep sternal cultures become available. The same cannot be said for the negative predictive value of gram-positive cultures as CoNS was cultured on a few occasions from deep tissue, when other samples were culture-negative.
Our study promotes the value of a superficial swab to predict pathogens implicated in a 'deep' infection in what was hitherto of seemingly dubious significance. Possible explanations for this observation maybe due to differences between DSWI and other 'deep' infections [e.g. osteomyelitis (other than the sternum)] such as the following: One limitation of this study is that it addresses the issue of microbiological diagnosis only and not the diagnosis of a 'deep' infection per se. The diagnosis of DSWI still relies on the clinical background together with operative, radiological and microbiological findings. With regard to the predictive values, the performance may be exaggerated in either direction due to small numbers in each organism group. The other limitations are attributed to its retrospective nature whereby superficial swabs were either not done as a routine or not reported with the same detail as a deep swab. A number of confounders were not accounted for, such as the duration of antibiotics ( prophylactic or pre-emptive) prior to each swab or tissue sample. There was and continues to be variability in the number of deep samples taken which would affect its yield and therefore the final diagnosis of DSWI. And lastly this study addressed only the first instances of post-operative DSWI and excluded re-operations for complications that may have been infection-related.
CONCLUSIONS
Superficial sternal swabs together with blood cultures perform well in predicting the microbiological aetiology of DSWI. Antibiotic prophylaxis, surgical antisepsis and nasal decolonization are already of proven benefit in prevention of DSWI [4, 20] . Additional improvements in the outcome are likely to accrue from early optimization of antibiotic therapy based on early culture results. This is particularly relevant to infections with MSSA. Where DSWI is suspected, an early microbiological diagnosis is possible with mandatory testing and reporting of superficial swabs and blood cultures. The other anticipated benefits from early antibiotic rationalization include fewer potential antibiotic adverse drug reactions, greater cost-effectiveness and lesser potential to develop resistant organisms. Most importantly, for the benefit of the individual patient, early rationalization may improve morbidity and mortality. Prospective studies are needed to compare the outcomes of early rationalization of antibiotics based on superficial swabs and blood cultures versus prolonged empirical broad-spectrum antibiotic treatment.
